MeiraGTx Holdings (MGTX) Depreciation and Depletion (2017 - 2020)
MeiraGTx Holdings (MGTX) posted Depreciation and Depletion of $879143.0 for Q4 2020, down 17.46% on a QoQ basis from $1.1 million in Q3 2020, and up 31.32% year-over-year from $669462.0 in Q1 2020.
MeiraGTx Holdings (MGTX) Depreciation and Depletion (2017 - 2020) Analysis & Trends
MeiraGTx Holdings' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $879143.0 for Q4 2020.
- Quarterly Depreciation and Depletion rose 31.32% year-over-year to $879143.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $3.7 million (up 65.28% YoY) and the FY2022 annual result came in at $7.3 million, up 15.87% from the prior year.
- Depreciation and Depletion was $879143.0 for Q4 2020 at MeiraGTx Holdings, down from $1.1 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $1.1 million in Q3 2020 and bottomed at $99481.0 in Q4 2017.
- A 4-year average of $592691.5 and a median of $535624.5 in 2018 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2018 — Depreciation and Depletion surged 406.16% — and 2019, when it dropped 3.52%.
- MeiraGTx Holdings' Depreciation and Depletion stood at $99481.0 in 2017, then jumped by 406.16% to $503534.0 in 2018, then soared by 32.95% to $669462.0 in 2019, then jumped by 31.32% to $879143.0 in 2020.
- Business Quant data shows MGTX's Depreciation and Depletion at $879143.0 in Q4 2020, $1.1 million in Q3 2020, and $940316.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 879,143.00 |
| Dec 31, 2020 | 879,143.00 |
| Sep 30, 2020 | 1.07 Mn |
| Sep 30, 2020 | 1.07 Mn |
| Jun 30, 2020 | 940,316.00 |
| Jun 30, 2020 | 940,316.00 |
| Mar 31, 2020 | 815,423.00 |
| Mar 31, 2020 | 815,423.00 |
| Dec 31, 2019 | 669,462.00 |
| Dec 31, 2019 | 669,462.00 |
| Sep 30, 2019 | 532,815.00 |
| Sep 30, 2019 | 532,815.00 |
| Jun 30, 2019 | 536,642.00 |
| Jun 30, 2019 | 536,642.00 |
| Mar 31, 2019 | 499,641.00 |
| Mar 31, 2019 | 499,641.00 |
| Dec 31, 2018 | 503,534.00 |
| Dec 31, 2018 | 503,534.00 |
| Sep 30, 2018 | 534,607.00 |
| Sep 30, 2018 | 534,607.00 |